Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739921 · ClinicalTrials.gov registry record · NA
The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA
A NA study of Sinusitis and Nasal Polyps, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT00739921 is a NA study of Sinusitis and Nasal Polyps that has completed, run by University of California, San Francisco. The registered enrollment target is 260 participants, above the 109-participant average among 12 other Sinusitis trials with a reported enrollment target (139% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00739921, a NA study of Sinusitis and Nasal Polyps, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine whether the amount or type of fungal DNA present in the nose and home environment can be correlated with the outcomes of the following quality of life (QOL) instruments: Medical Outcomes Study 36-item Short Form (SF-36) and the Sino-Nasal Outcomes Study - 20 Questions (SNOT-20).
Conditions Studied
Interventions
- PROCEDURE Nasal swab under endoscopic guidance
Study Locations (1)
California
- University of California, San Francisco, Dept of Otolaryngology-HNS - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2006-06 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00739921
The ClinicalTrials.gov registry entry for NCT00739921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 109-participant average among 12 other Sinusitis trials with a reported enrollment target (139% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sinusitis appearing as the primary indexed condition, and to 1 intervention - of which Nasal swab under endoscopic guidance is the first listed.
NCT00739921 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00739921 about?
NCT00739921 is a clinical study titled "The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA". The objective of this study is to determine whether the amount or type of fungal DNA present in the nose and home environment can be correlated with the outcomes of the following quality of life (QOL) instruments: Medical Outcomes Study 36-item Short Form (SF-36) and the Sino-Nasal Outcomes Study - ...
What is the current status of trial NCT00739921?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2006-06. Estimated completion is 2015-05.
What conditions does trial NCT00739921 study?
This clinical trial studies the following conditions: Sinusitis, Nasal Polyps.
What interventions are being tested in trial NCT00739921?
The interventions under investigation include: Nasal swab under endoscopic guidance (PROCEDURE).
Who is sponsoring clinical trial NCT00739921?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00739921 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
High Resolution Micro OCT Imaging
ACTIVE NOT RECRUITING
-
Dupixent Study for Alternate Administration
ACTIVE NOT RECRUITING · Phase 4
-
Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care
ACTIVE NOT RECRUITING
-
A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
COMPLETED · Phase 2
-
Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.